Search details
1.
Synthetic lethality-mediated precision oncology via the tumor transcriptome.
Cell
; 184(9): 2487-2502.e13, 2021 04 29.
Article
in English
| MEDLINE | ID: mdl-33857424
2.
Snapshot: Trial Types in Precision Medicine.
Cell
; 181(1): 208-208.e1, 2020 04 02.
Article
in English
| MEDLINE | ID: mdl-32243791
3.
The Master Observational Trial: A New Class of Master Protocol to Advance Precision Medicine.
Cell
; 180(1): 9-14, 2020 01 09.
Article
in English
| MEDLINE | ID: mdl-31951522
4.
Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus.
Cell
; 171(5): 982-986, 2017 Nov 16.
Article
in English
| MEDLINE | ID: mdl-29149611
5.
OX40/OX40 ligand and its role in precision immune oncology.
Cancer Metastasis Rev
; 2024 Mar 25.
Article
in English
| MEDLINE | ID: mdl-38526805
6.
Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 166(5): 859-871.e3, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38280684
7.
Revolutionizing cancer drug development: Harnessing the potential of basket trials.
Cancer
; 130(2): 186-200, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37934000
8.
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
Cancer
; 2024 Feb 15.
Article
in English
| MEDLINE | ID: mdl-38358334
9.
Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis.
Oncologist
; 29(2): e213-e223, 2024 Feb 02.
Article
in English
| MEDLINE | ID: mdl-37589222
10.
Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
BMC Med
; 22(1): 74, 2024 Feb 19.
Article
in English
| MEDLINE | ID: mdl-38369520
11.
Carcinoma of unknown primary: Molecular tumor board-based therapy.
CA Cancer J Clin
; 72(6): 510-523, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36006378
12.
Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer.
Int J Mol Sci
; 25(9)2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38731962
13.
Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
Semin Cancer Biol
; 84: 50-59, 2022 09.
Article
in English
| MEDLINE | ID: mdl-32950605
14.
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.
Br J Cancer
; 128(12): 2227-2235, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37087488
15.
Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
Oncologist
; 28(2): e82-e91, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-36082904
16.
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer.
Oncologist
; 27(9): 732-739, 2022 09 02.
Article
in English
| MEDLINE | ID: mdl-35598202
17.
Cutaneous perivascular epithelioid cell tumor (PEComa): case report and world literature review of clinical and molecular characteristics.
Dermatol Online J
; 28(1)2022 Jan 15.
Article
in English
| MEDLINE | ID: mdl-35499412
18.
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 22(9): 1290-1300, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34339623
19.
Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers.
Int J Cancer
; 148(3): 702-712, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-32700810
20.
High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment.
Int J Cancer
; 148(11): 2839-2847, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-33497479